Home symptom care for lung cancer patients on drug therapy
Part of Cancer, Lungs & breathing clinical trials.
This study tests a smartphone-based program to help people with lung cancer manage symptoms at home while they receive combination drug therapy. It aims to see if this program is practical and helpful for patients, possibly improving their daily well-being during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a lung cancer diagnosis that has been confirmed (by a biopsy or lab test).
- You are about to start or are currently receiving your first combination drug therapy for lung cancer, with treatment planned for at least 4 cycles.
- You are able to use a smartphone (like an iPhone or Android device).
- You feel well enough to be at home and manage daily activities (the doctor uses a scale called ECOG, and you need a score of 2 or less, which means you are capable of self-care).
- You know your own diagnosis and your medication plan, and you are willing to join the study voluntarily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone-based program to help people with advanced lung cancer manage their symptoms and daily life. The program uses WhatsApp or WeChat to provide support and aims to improve quality of life.
This trial tests a “whole process follow-up” care plan, using a smartphone, to support people with non-small cell lung cancer from diagnosis through treatment and follow-up. It may help you manage care steps more smoothly if you’re not a candidate for curative (radical) treatment or don’t want surgery.
This trial tests whether using a smartphone app to report symptoms can help patients stick to their recovery exercises after minimally invasive lung cancer surgery. If you are having surgery for lung cancer, this study may help you recover better at home.
This trial tests whether using a web-based tool to track symptoms can help people with advanced lung cancer live longer and feel better. You would report symptoms regularly, and your care team would use that information to adjust your care.
This trial tests a digital health tool to help lung cancer patients improve their physical function and wellness during and after treatment. It is designed for people with early-stage lung cancer who are starting treatment with chemotherapy, immunotherapy, or radiation.
This study tests a mobile app (called THRIVE) to help people with advanced lung cancer manage their health and well-being. You'll use the app on your phone to track symptoms and get support, which may help you feel better and stay more in control.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.